Experimental Alzheimer's Drug Slows Thinking Declines in Late-Stage Trial

MONDAY, July 17, 2023 (HealthDay News) -- Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing

Related Keywords

Harvard School Of Public Health ,Massachusetts ,United States ,Boston ,San Francisco ,California ,Amsterdam ,Noord Holland ,Netherlands ,American ,Anne White ,Eli Lilly ,Gil Rabinovici ,Los Angeles ,Mark Mintun ,Eric Widera ,Meredith Rosenthal ,Taub Institute For Research On Alzheimer Disease ,Alzheimer Association International Conference ,Brain At Columbia University ,Drug Administration ,University Of California ,Journal Of The American Medical Association ,Healthday News ,American Medical Association ,Association International Conference ,Lilly Neuroscience ,Jennifer Manly ,Kacie Deters ,Taub Institute ,Aging Brain ,Columbia University ,Renaud La Joie ,Harvard School ,Public Health ,Affordable Care Act ,Tncen ,Consumer News ,